Tom Vonderlach

Chief Scientific Officer
Vivtex Corporation

Disclosure information not submitted.

Presentation(s):

• 7 - Pre-clinical screening of permeation enhancers for oral peptide administration in oral dosage forms: update on GI-ORIS

  Monday, July 14, 2025
  11:00 AM – 11:30 AM EDT